Answer
Oestrogens, which are moderate CYP1A2 inhibitors, increase agomelatine exposure several-fold when used together, although no specific safety signal was observed in 800 patients receiving the combination.
Sources for this answer
- ValdoxanServier Laboratories Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 20Document updated
Sources checked